Umashanker Navik

2.8k total citations · 3 hit papers
48 papers, 2.0k citations indexed

About

Umashanker Navik is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Umashanker Navik has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Umashanker Navik's work include Pancreatic function and diabetes (7 papers), Liver physiology and pathology (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Umashanker Navik is often cited by papers focused on Pancreatic function and diabetes (7 papers), Liver physiology and pathology (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Umashanker Navik collaborates with scholars based in India, Germany and United States. Umashanker Navik's co-authors include Jasvinder Singh Bhatti, Amit Khurana, Pushkar Singh Rawat, Gurjit Kaur Bhatti, Prince Allawadhi, P. Hemachandra Reddy, Jayapriya Mishra, Naina Khullar, Kala Kumar Bharani and Abhishek Sehrawat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and ACS Applied Materials & Interfaces.

In The Last Decade

Umashanker Navik

47 papers receiving 1.9k citations

Hit Papers

Doxorubicin-induced cardi... 2021 2026 2022 2024 2021 2022 2022 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
    2021 584 citations Amit Khurana, Jasvinder Singh Bhatti et al. profile →
  2. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives
    2022 387 citations Jasvinder Singh Bhatti, Abhishek Sehrawat et al. Free Radical Biology and Medicine profile →
  3. Gene therapy: Comprehensive overview and therapeutic applications
    2022 186 citations Prince Allawadhi, Amit Khurana et al. Life Sciences profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Umashanker Navik 796 355 197 192 191 48 2.0k
Ada Popolo 980 1.2× 358 1.0× 273 1.4× 192 1.0× 122 0.6× 58 2.5k
Hamed Haghi‐Aminjan 584 0.7× 160 0.5× 221 1.1× 276 1.4× 109 0.6× 74 1.9k
Vincenzo Quagliariello 543 0.7× 304 0.9× 353 1.8× 118 0.6× 180 0.9× 63 1.9k
Punniyakoti T. Veeraveedu 1.0k 1.3× 689 1.9× 175 0.9× 257 1.3× 336 1.8× 96 3.1k
Vilma A. Sardão 1.2k 1.5× 575 1.6× 347 1.8× 302 1.6× 120 0.6× 66 2.4k
Hua Li 963 1.2× 207 0.6× 153 0.8× 173 0.9× 77 0.4× 78 2.2k
Xiangchun Shen 1.3k 1.6× 137 0.4× 247 1.3× 104 0.5× 104 0.5× 200 2.9k
Alireza Garjani 810 1.0× 206 0.6× 110 0.6× 162 0.8× 235 1.2× 103 2.2k
Woo Hyun Park 1.9k 2.4× 143 0.4× 315 1.6× 175 0.9× 91 0.5× 138 3.1k
Matthias Rath 723 0.9× 187 0.5× 241 1.2× 98 0.5× 159 0.8× 150 2.9k

Countries citing papers authored by Umashanker Navik

Since Specialization
Citations

This map shows the geographic impact of Umashanker Navik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umashanker Navik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umashanker Navik more than expected).

Fields of papers citing papers by Umashanker Navik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umashanker Navik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umashanker Navik. The network helps show where Umashanker Navik may publish in the future.

Co-authorship network of co-authors of Umashanker Navik

This figure shows the co-authorship network connecting the top 25 collaborators of Umashanker Navik. A scholar is included among the top collaborators of Umashanker Navik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umashanker Navik. Umashanker Navik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ahmad, Anas, Ajay Kumar, Rahul Sakla, et al.. (2024). Leveraging thiol-functionalized biomucoadhesive hybrid nanoliposome for local therapy of ulcerative colitis. Biomaterials. 312. 122747–122747. 11 indexed citations
3.
4.
Navik, Umashanker, et al.. (2024). Artemisinin Ameliorates the Neurotoxic Effect of 3-Nitropropionic Acid: A Possible Involvement of the ERK/BDNF/Nrf2/HO-1 Signaling Pathway. Molecular Neurobiology. 62(3). 3583–3600. 2 indexed citations
5.
Khullar, Naina, et al.. (2024). Multifaceted role of dynamin-related protein 1 in cardiovascular disease: From mitochondrial fission to therapeutic interventions. Mitochondrion. 78. 101904–101904. 8 indexed citations
6.
Khullar, Naina, et al.. (2024). Nutrient-epigenome interactions: Implications for personalized nutrition against aging-associated diseases. The Journal of Nutritional Biochemistry. 127. 109592–109592. 7 indexed citations
7.
Sehrawat, Abhishek, et al.. (2023). Betaine alleviates doxorubicin‐induced nephrotoxicity by preventing oxidative insults, inflammation, and fibrosis through the modulation of Nrf2/HO−1/NLRP3 and TGF‐β expression. Journal of Biochemical and Molecular Toxicology. 38(1). e23559–e23559. 15 indexed citations
8.
Mishra, Jayapriya, Umashanker Navik, Ramesh Kandimalla, et al.. (2023). Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions. Life Sciences. 328. 121882–121882. 36 indexed citations
9.
Khurana, Amit, Prince Allawadhi, Sachin Allwadhi, et al.. (2023). Antimicrobial and anti-viral effects of selenium nanoparticles and selenoprotein based strategies: COVID-19 and beyond. Journal of Drug Delivery Science and Technology. 86. 104663–104663. 15 indexed citations
10.
Arora, Sahil, et al.. (2023). ALK and ERBB2 Protein Inhibition is Involved in the Prevention of Lung CancerDevelopment by Vincamine. Anti-Cancer Agents in Medicinal Chemistry. 23(13). 1587–1595. 3 indexed citations
11.
Tiwari, Apoorv, Usman Ali, Meena Krishania, et al.. (2023). A comparative study of colored wheat lines across laboratories for validation of their phytochemicals and antioxidant activity. Journal of Cereal Science. 112. 103719–103719. 23 indexed citations
12.
Sehrawat, Abhishek, Jayapriya Mishra, Sarabjit Mastana, et al.. (2023). Dysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(4). 166666–166666. 30 indexed citations
13.
Navik, Umashanker, et al.. (2023). Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach. Advanced Therapeutics. 7(2). 10 indexed citations
14.
Navik, Umashanker, et al.. (2022). Repurposing artemisinins as neuroprotective agents: a focus on the PI3k/Akt signalling pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(4). 593–605. 12 indexed citations
15.
Bhatti, Jasvinder Singh, Abhishek Sehrawat, Jayapriya Mishra, et al.. (2022). Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. Free Radical Biology and Medicine. 184. 114–134. 387 indexed citations breakdown →
16.
Khurana, Amit, et al.. (2022). Glucagon-like peptide 1 and fibroblast growth factor-21 in non-alcoholic steatohepatitis: An experimental to clinical perspective. Pharmacological Research. 184. 106426–106426. 22 indexed citations
17.
18.
Bhatti, Gurjit Kaur, Naina Khullar, Satwinder Singh, et al.. (2022). Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases. Biomedical Journal. 45(5). 733–748. 36 indexed citations
19.
Khurana, Isha, Prince Allawadhi, Amit Khurana, et al.. (2021). Can bilirubin nanomedicine become a hope for the management of COVID-19?. Medical Hypotheses. 149. 110534–110534. 28 indexed citations
20.
Navik, Umashanker, et al.. (2020). Unveiling the presence of epigenetic mark by Lactobacillus supplementation in high-fat diet-induced metabolic disorder in Sprague-Dawley rats. The Journal of Nutritional Biochemistry. 84. 108442–108442. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ada Popolo Breakdown of academic impact, for papers by Hamed Haghi‐Aminjan Breakdown of academic impact, for papers by Vincenzo Quagliariello Breakdown of academic impact, for papers by Punniyakoti T. Veeraveedu Breakdown of academic impact, for papers by Vilma A. Sardão Breakdown of academic impact, for papers by Hua Li Breakdown of academic impact, for papers by Xiangchun Shen Breakdown of academic impact, for papers by Alireza Garjani Breakdown of academic impact, for papers by Woo Hyun Park Breakdown of academic impact, for papers by Matthias Rath
Rankless by CCL
2026